P-4EBP1 expression significantly decreased during treatment in all 21 examined ALL cases, with a concomitant reduction in the percentage of lymphoblasts (0–10% of bone marrow mononuclear cells). This evidence concerns the gene EIF4EBP1 and acute lymphoblastic leukemia.